"Visitation restrictions are currently in place to decrease possible exposure to Coronavirus (COVID-19). Please visit our website for more information. CHI Health Mercy Council Bluffs is dedicated to delivering high quality, compassionate care to Council Bluffs and nearby communities. Visit us at 800 Mercy Dr or call (712) 328-5000 for more information."

During the past decade, Alegent Health Mercy Hospital conducted 127 clinical trials. In the 10-year time frame, 127 clinical trials started and 50 clinical trials were completed, i.e. on average, 39.4% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 44 clinical trials were completed. i.e. 84.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alegent Health Mercy Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 77 trials, followed by "SWOG Cancer Research Network" with 31 trials sponsored, "Alliance for Clinical Trials in Oncology" with 26 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alegent Health Mercy Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 86 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Alegent Health Mercy Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Recurrent Ovarian Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Breast Cancer" (6 trials). Many other conditions were trialed in "Alegent Health Mercy Hospital" in a lesser frequency.

Most popular intervention types in "Alegent Health Mercy Hospital" are "Drug" (130 trials), "Other" (98 trials), "Biological" (74 trials), "Procedure" (43 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (47 trials), "Quality-of-Life Assessment" (38 trials), "Computed Tomography" (25 trials), "Nivolumab" (25 trials) and "Questionnaire Administration" (24 trials). Other intervention names were less common.

The vast majority of trials in "Alegent Health Mercy Hospital" are 131 trials for "All" genders, 27 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Alegent Health Mercy Hospital". undefined are not yet recruiting, 52 are recruiting, 74 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Alegent Health Mercy Hospital, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Alegent Health Mercy Hospital, 4 "Phase 1" clinical trials were conducted, 79 "Phase 2" clinical trials and 82 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".